# FDA Inspection 1262260 - Rebel Converting LLC - February 24, 2025

Source: https://www.keypedia.com/records/fda_inspections/rebel-converting-llc/2b9ac15d-b5d3-429c-84da-5539e061629a
Source feed: FDA_Inspections

> FDA Inspection 1262260 for Rebel Converting LLC on February 24, 2025. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1262260
- Company Name: Rebel Converting LLC
- Inspection Date: 2025-02-24
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1249180 - 2024-09-12](https://www.keypedia.com/records/fda_inspections/rebel-converting-llc/2ac8c23f-0108-4381-ae9e-d8e203b769e6)
- [FDA Inspection 1249180 - 2024-09-12](https://www.keypedia.com/records/fda_inspections/rebel-converting-llc/6c81b995-00fe-4dc8-8aa6-133e16edead3)

Company: https://www.keypedia.com/companies/rebel-converting-llc/cbd7d971-fd0d-43e0-be52-06e4b6ad7fe8

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c